BAT Investor Conference Presentation Deck
H1 2022 - Transforming and Delivering
Delivering robust
financial results
Transforming
our business
20.4m adult consumers of
Non-Combustible products
45% New Category revenue
growth**
50%+ (£281m) reduction in
New Category losses****
Strong brands powered by
innovation
Group revenue up +5.7%;
+3.7% at constant FX**
Reported diluted EPS down
-42.9%
Adjusted diluted EPS up
+5.7% at constant FX^
Confident in delivering FY22
guidance
●
BAT
Successfully navigating
the macro environment
●
A BETTER TOMORROW
£1.5bn Quantum savings
delivered 6 months ahead of
target
90bps improvement in adjusted
operating margin to 43.9%^^
Robust pricing - achieved c.90%
of planned pricing
£3.8bn YTD cash returns to shareholders: £2.5bn Dividends and £1.3bn Buyback
Reducing the health impact of our business. Based on the weight of evidence and assuming a complete switch from cigarette smoking. These products are not risk free and are addictive. Our products as sold in the US, including Vuse, Velo,
Grizzly, Kodiak, and Camel Snus, are subject to FDA regulation and no reduced-risk claims will be made as to these products without agency clearance. These products are not risk free and are addictive. * See Appendix A3 ** At constant rates. See
Appendix A2. *** Reduction versus H1'21 at constant rates at category contribution level: Profit from the sales of brands after deduction of directly attributable costs (including R&D, marketing) and before allocation of overheads. See Appendix A2..
^On an adjusted constant rate basis. See Appendix A1 and A2. ^^ On an adjusted basis at current adjusted rates. See Appendix A1.
5View entire presentation